Enovis Corporation ENOV
ENOV Rating
ENOV Rating Factors
ENOV Company Overview
Enovis Corporation (NYSE: ENOV) is a U.S.-based medical technology company focused on orthopedic and rehabilitation solutions. The company develops, manufactures, and markets products used in injury prevention, pain management, reconstructive surgery, and patient rehabilitation. Enovis operates primarily within the global musculoskeletal healthcare industry, serving hospitals, ambulatory surgery centers, orthopedic surgeons, physical therapists, prosthetists, and patients. Its core revenue drivers include orthopedic reconstruction implants, surgical technologies, bracing and support products, rehabilitation systems, and customized prosthetic solutions.
The company traces its roots to Colfax Corporation, an industrial manufacturing business founded in 1995. Following a series of healthcare-focused acquisitions and strategic repositioning, Colfax separated from much of its industrial portfolio and rebranded as Enovis Corporation in 2022 to reflect its concentration on medical technology. Enovis has since emphasized innovation in orthopedic reconstruction and patient mobility, positioning itself as a growth-oriented medtech company with integrated procedural and post-operative care capabilities.
ENOV Income Statement
ENOV Balance Sheet
ENOV Price History
ENOV Valuation
ENOV Dividends and Shares
ENOV Corporate Info
Suite 200
Lewisville, TX 75067